These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19294996)

  • 41. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Loria P; Lonardo A; Carulli N
    Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
    Nash S; Marconi S; Sikorska K; Naeem R; Nash G
    Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nash, insulin resistance and iron.
    Machado M; Cortez-Pinto H
    Liver Int; 2006 Dec; 26(10):1159-62. PubMed ID: 17105580
    [No Abstract]   [Full Text] [Related]  

  • 45. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
    Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
    Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adipocyte iron regulates adiponectin and insulin sensitivity.
    Gabrielsen JS; Gao Y; Simcox JA; Huang J; Thorup D; Jones D; Cooksey RC; Gabrielsen D; Adams TD; Hunt SC; Hopkins PN; Cefalu WT; McClain DA
    J Clin Invest; 2012 Oct; 122(10):3529-40. PubMed ID: 22996660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease.
    Manco M; Alisi A; Real JF; Equitani F; DeVito R; Valenti L; Nobili V
    J Hepatol; 2011 Sep; 55(3):647-653. PubMed ID: 21168460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
    Townsend A; Drakesmith H
    Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.
    Valenti L; Dongiovanni P; Piperno A; Fracanzani AL; Maggioni M; Rametta R; Loria P; Casiraghi MA; Suigo E; Ceriani R; Remondini E; Trombini P; Fargion S
    Hepatology; 2006 Oct; 44(4):857-64. PubMed ID: 17006922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of iron in nonalcoholic fatty liver disease: the story continues.
    Kowdley KV
    Gastroenterology; 2010 Mar; 138(3):817-9. PubMed ID: 20116466
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload.
    Henninger B; Kremser C; Rauch S; Eder R; Zoller H; Finkenstedt A; Michaely HJ; Schocke M
    Eur Radiol; 2012 Nov; 22(11):2478-86. PubMed ID: 22645044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
    Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
    J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.
    Valenti L; Rametta R; Dongiovanni P; Motta BM; Canavesi E; Pelusi S; Pulixi EA; Fracanzani AL; Fargion S
    PLoS One; 2012; 7(11):e48804. PubMed ID: 23144979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.
    George DK; Goldwurm S; MacDonald GA; Cowley LL; Walker NI; Ward PJ; Jazwinska EC; Powell LW
    Gastroenterology; 1998 Feb; 114(2):311-8. PubMed ID: 9453491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fargion S
    World J Gastroenterol; 2012 Aug; 18(29):3782-6. PubMed ID: 22876027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3.
    MacDonald GA; Bridle KR; Ward PJ; Walker NI; Houglum K; George DK; Smith JL; Powell LW; Crawford DH; Ramm GA
    J Gastroenterol Hepatol; 2001 Jun; 16(6):599-606. PubMed ID: 11422610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.